These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9581818)
1. Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1. Ono M; Morisawa K; Nie J; Ota K; Taniguchi T; Saibara T; Onishi S Cancer Res; 1998 May; 58(9):1813-6. PubMed ID: 9581818 [TBL] [Abstract][Full Text] [Related]
2. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis. Jakubczak JL; Chisari FV; Merlino G Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis. Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999 [TBL] [Abstract][Full Text] [Related]
4. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells. Gallina A; Gazina E; Milanesi G Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551 [TBL] [Abstract][Full Text] [Related]
6. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947 [TBL] [Abstract][Full Text] [Related]
7. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. Caselmann WH J Hepatol; 1995; 22(1 Suppl):34-7. PubMed ID: 7602073 [TBL] [Abstract][Full Text] [Related]
8. The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinoma. Gwak GY; Lee DH; Moon TG; Choi MS; Lee JH; Koh KC; Paik SW; Park CK; Joh JW; Yoo BC Hepatogastroenterology; 2008; 55(88):2028-32. PubMed ID: 19260471 [TBL] [Abstract][Full Text] [Related]
9. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice. Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418 [TBL] [Abstract][Full Text] [Related]
10. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152 [TBL] [Abstract][Full Text] [Related]
11. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132 [TBL] [Abstract][Full Text] [Related]
13. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226 [TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. Marotta F; Vangieri B; Cecere A; Gattoni A Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567 [TBL] [Abstract][Full Text] [Related]
15. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter]. Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629 [TBL] [Abstract][Full Text] [Related]
16. HBV surface antigen proteins with deletions in the preS region. Xu K; Yu X; Kong Y; Wang Y; Li Z Sci China B; 1995 Mar; 38(3):320-7. PubMed ID: 7766314 [TBL] [Abstract][Full Text] [Related]
17. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha. Vail ME; Pierce RH; Fausto N Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255 [TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of hepatitis C Virus E2 glycoprotein fused to hepatitis B virus preS1(21-47) fragment in CHO cells. Wang CL; Zhu LX; Liu J; Zhang ZC; Wang Y; Li GD Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):400-4. PubMed ID: 12098759 [TBL] [Abstract][Full Text] [Related]
20. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County. Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]